KIOVIG sol perf 2.5 g/25ml i.v. flac 25 ml

7680574690024 CH-57469 J06BA02 08.09.

Reimbursement limitations:

INTRATECT2

Admis uniquement en cas de déficits immunitaires, de purpuras idiopathiques thrombocytopéniques, de syndrome de Guillain-Barré, …

KIOVIG sol perf 2.5 g/25ml i.v. flac 25 ml
KIOVIG sol perf 2.5 g/25ml i.v. flac 25 ml
KIOVIG sol perf 2.5 g/25ml i.v. flac 25 ml
1 / 3
google

Details

Product number
5746901
CPT
-
Packaging group
25
Unit
ml
Composition
immunoglobulinum humanum normale 100 mg, glycinum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Articles (1)

Kiovig, Infusionslösung
Infusionslösung
25
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
30/01/2024
Professional SmPC
Français
30/01/2024
Professional SmPC
Italien
30/01/2024

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 201.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2006

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
57469
Drug name
Kiovig, Infusionslösung
Galenic form
LSINF
ATC Code
J06BA02
Authorization status
Z
Dispensation category
B
First authorization
06/12/2005
Authorization expiration date
31/12/9999
IT number
08.09.
Domain
Human medicine
Field of application
humanes Immunglobulin G

Packaging details

Description (FR)
KIOVIG sol perf 2.5 g/25ml i.v. flac 25 ml
Description (DE)
KIOVIG Inf Lös 2.5 g/25ml i.v. Durchstf 25 ml
Market launch
06/12/2005
Narcotic (BTM)
No

Application methods

IV

Other packaging sizes

KIOVIG sol perf 5 g/50ml i.v. flac 50 ml
50 ML
View
KIOVIG sol perf 10 g/100ml i.v. flac 100 ml
100 ML
View
KIOVIG sol perf 20 g/200ml i.v. flac 200 ml
200 ML
View
KIOVIG sol perf 30 g/300ml i.v. flac 300 ml
300 ML
View